Embecta Corp. Common Stock EMBC
i
Market dataready · fetched 2026-11-12T01:29:19.153Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T22:38:25.843944035Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-12T01:29:18.224234+00:00
Embecta Corp. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 5.53 | 109.0% | 23.6% | |||
| 25Δ | 5.92 | 128.3% | 23.0% | |||
| 30Δ | 6.30 | 147.5% | 22.3% | |||
| 35Δ | 6.69 | 166.7% | 21.7% | |||
| 40Δ | 7.07 | 186.0% | 21.0% | |||
| 45Δ | 6.80 | 103.2% | 17.6% | 7.45 | 205.2% | 20.4% |
| 50Δ | 6.52 | 113.0% | 16.4% | 7.78 | 196.9% | 18.2% |
| 55Δ | 6.25 | 122.8% | 15.1% | 8.10 | 184.8% | 15.8% |
| 60Δ | 5.97 | 132.6% | 13.9% | 8.42 | 172.7% | 13.5% |
| 65Δ | 5.69 | 142.4% | 12.6% | 8.73 | 160.6% | 11.1% |
| 70Δ | 5.42 | 152.2% | 11.4% | 9.05 | 148.5% | 8.7% |
| 75Δ | 5.14 | 162.0% | 10.1% | 9.37 | 136.4% | 6.4% |
| 80Δ | 9.69 | 124.3% | 4.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.53
- IV
- 109.0%
- B/E move
- 23.6%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.92
- IV
- 128.3%
- B/E move
- 23.0%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.30
- IV
- 147.5%
- B/E move
- 22.3%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.69
- IV
- 166.7%
- B/E move
- 21.7%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.07
- IV
- 186.0%
- B/E move
- 21.0%
45Δ
- Pseudo strike
- 6.80
- IV
- 103.2%
- B/E move
- 17.6%
- Pseudo strike
- 7.45
- IV
- 205.2%
- B/E move
- 20.4%
50Δ
- Pseudo strike
- 6.52
- IV
- 113.0%
- B/E move
- 16.4%
- Pseudo strike
- 7.78
- IV
- 196.9%
- B/E move
- 18.2%
55Δ
- Pseudo strike
- 6.25
- IV
- 122.8%
- B/E move
- 15.1%
- Pseudo strike
- 8.10
- IV
- 184.8%
- B/E move
- 15.8%
60Δ
- Pseudo strike
- 5.97
- IV
- 132.6%
- B/E move
- 13.9%
- Pseudo strike
- 8.42
- IV
- 172.7%
- B/E move
- 13.5%
65Δ
- Pseudo strike
- 5.69
- IV
- 142.4%
- B/E move
- 12.6%
- Pseudo strike
- 8.73
- IV
- 160.6%
- B/E move
- 11.1%
70Δ
- Pseudo strike
- 5.42
- IV
- 152.2%
- B/E move
- 11.4%
- Pseudo strike
- 9.05
- IV
- 148.5%
- B/E move
- 8.7%
75Δ
- Pseudo strike
- 5.14
- IV
- 162.0%
- B/E move
- 10.1%
- Pseudo strike
- 9.37
- IV
- 136.4%
- B/E move
- 6.4%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 9.69
- IV
- 124.3%
- B/E move
- 4.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 96.47% | |
| 84.29% | |
| 110.78% | |
| 89.24% | |
| 171.56% | |
| 151.57% |
Medical Instruments & Supplies
ICUI
ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente,…
More →ISRG
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally…
More →KRMD
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the…
More →LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is…
More →MDLN
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States…
More →MMED
Description unavailable
More →